Low dose of interferon-α improves the clinical outcomes of docetaxel in patients with castration-resistant prostate cancer: A pilot study
about
Unraveling the convoluted biological roles of type I interferons in infection and immunity: a way forward for therapeutics and vaccine design.Interferon inducible antiviral MxA is inversely associated with prostate cancer and regulates cell cycle, invasion and Docetaxel induced apoptosis.Antitumor activity of interferon-β1a in hormone refractory prostate cancer with neuroendocrine differentiation.
P2860
Low dose of interferon-α improves the clinical outcomes of docetaxel in patients with castration-resistant prostate cancer: A pilot study
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Low dose of interferon-α impro ...... prostate cancer: A pilot study
@en
Low dose of interferon-α impro ...... rostate cancer: A pilot study.
@nl
type
label
Low dose of interferon-α impro ...... prostate cancer: A pilot study
@en
Low dose of interferon-α impro ...... rostate cancer: A pilot study.
@nl
prefLabel
Low dose of interferon-α impro ...... prostate cancer: A pilot study
@en
Low dose of interferon-α impro ...... rostate cancer: A pilot study.
@nl
P2093
P2860
P356
P1433
P1476
Low dose of interferon-α impro ...... prostate cancer: A pilot study
@en
P2093
Guo-Fu Ding
Jiang-Ping Wang
Qin-Zhang Wang
Tao-Tao Zhang
Yun-Fei Li
P2860
P304
P356
10.3892/OL.2013.1653
P577
2013-11-01T00:00:00Z